Holen Sie sich die Stockscreener-App
0.599
0.71%
0.049
Schlusskurs vom Vortag:
$0.55
Offen:
$0.57
24-Stunden-Volumen:
11,558
Relative Volume:
0.22
Marktkapitalisierung:
$2.90M
Einnahmen:
$5.54M
Nettoeinkommen (Verlust:
$-4.74M
KGV:
-1.7827
EPS:
-0.336
Netto-Cashflow:
$-750.60K
1W Leistung:
-0.72%
1M Leistung:
-23.93%
6M Leistung:
-61.53%
1J Leistung:
-72.58%
1-Tages-Spanne:
$0.5491
$0.5985
1-Wochen-Bereich:
$0.5201
$0.60
52-Wochen-Spanne:
$0.5201
$3.18
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Firmenname
China Pharma Holdings Inc.
Sektor
Telefon
86 898 6681 1730
Adresse
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.5765 | 2.76M | 5.54M | -4.74M | -750.60K | -0.336 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.21 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.80 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.53 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
488.90 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2010-01-08 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten
China Pharma Expands R&D Portfolio With Patent Acquisition - TipRanks
Quarterly Risk: Can China Pharma Holdings Inc keep up with sector leadersJuly 2025 WrapUp & Fast Gain Stock Trading Tips - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
CPHI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Inflation Data: Is Blackstone Inc affected by consumer sentimentQuarterly Earnings Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Risk Check: Is China Pharma Holdings Inc part of any ETFQuarterly Growth Report & Smart Investment Allocation Insights - baoquankhu1.vn
Risk Analysis: Can NESRW lead its sector in growthShare Buyback & Trade Opportunity Analysis - baoquankhu1.vn
BIT Capital GmbH Reduces Holdings in BridgeBio Pharma, Inc. $BBIO - Defense World
CPHI Should I Buy - Intellectia AI
Winners Losers: Is GoldMining Inc part of any ETFMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
The China factor: US pharma group campaigns for increased competitiveness - Yahoo Finance
PAPLD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Profit Review: Should I set a stop loss on SGRPLayoff News & Technical Buy Zone Confirmation - baoquankhu1.vn
00863 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Most and least shorted healthcare stocks with up to $2B market cap - Seeking Alpha
Can China Pharma Holdings Inc. stock maintain growth trajectory2025 Investor Takeaways & Long-Term Safe Return Strategies - mfd.ru
Will China Pharma Holdings Inc. stock maintain momentum in 2025Gap Up & Verified Entry Point Detection - mfd.ru
What margin trends mean for China Pharma Holdings Inc. stockJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Published on: 2026-02-12 19:55:00 - mfd.ru
Is Gold Royalty Corp. currently under institutional pressure2025 Top Gainers & Stock Portfolio Risk Control - mfd.ru
Is China Pharma Holdings Inc. stock trending bullish2025 Key Highlights & AI Driven Price Predictions - mfd.ru
What’s next for Athira Pharma Inc. stockCPI Data & Pattern Based Trade Signal System - mfd.ru
Can China Pharma Holdings Inc. expand its profit marginsTrade Risk Report & Long-Term Safe Investment Ideas - mfd.ru
China Pharma to acquire patent through $8.82 million stock issuance By Investing.com - Investing.com India
China Pharma to acquire patent through $8.82 million stock issuance - Investing.com Nigeria
China Pharma Acquires Topiroxostat Patent Via Equity Issuance - TipRanks
Risk Check: Is PGEN stock a hidden gemPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Reactions: Can China Pharma Holdings Inc stock outperform in a bear marketJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Ascentage Pharma Receives Clearance from China’s CDE for New Drug - Yahoo Finance
Ascentage Pharma Group International Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - marketscreener.com
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
DSS, INC. (DSS) - MSN
Risk Off: Is GPATW part of any major index2025 Major Catalysts & Daily Oversold Bounce Ideas - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
China Pharma Holdings acquires patent in stock deal - MSN
What China SXT's 1-for-150 share consolidation means for holders - Stock Titan
Regeneron Earnings Report: Strategic Growth in 2025- Intellectia AI™ - Intellectia AI
Trading Recap: Is Suncor Energy Inc benefiting from interest rate changesBond Market & Weekly High Return Forecasts - baoquankhu1.vn
Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate - Yahoo Finance
Bear Alert: Does ALHC align with a passive investing strategyJuly 2025 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn
Resistance Check: Can China Pharma Holdings Inc expand its profit marginsTrade Exit Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
China halts sale of Sun Pharma drug used to treat dementia - Yahoo Finance
Merck KGaA (OTCMKTS:MKGAF) versus China Pharma (NYSE:CPHI) Financial Contrast - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Rally Mode: Will Century Casinos Inc benefit from geopolitical trendsRisk Management & Growth Oriented Trade Recommendations - baoquankhu1.vn
Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Increase in Short Interest - Defense World
Can Bitcoin Depot Inc. deliver consistent dividendsWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - bollywoodhelpline.com
Fed Meeting: How do insiders feel about National Health Investors IncMarket Performance Summary & Weekly High Momentum Picks - baoquankhu1.vn
Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):